Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
NEXT Life Sciences logo — NEXT Life Sciences Introduces Plan A™ A revolutionary, non-h...

NEXT Life Sciences

NEXT Life Sciences Introduces Plan A™ A revolutionary, non-hormonal, reversible procedure that will bring the scientific

Founded 2020 12 employees Seed Total: $1.55M Biotechnology, Life Sciences

General Information

Company Name NEXT Life Sciences
Founded Year 2020
Employees 12
Industries Biotechnology, Life Sciences
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with NEXT Life Sciences. To contact NEXT Life Sciences, visit nextlifesciences.org.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NEXT Life Sciences compare?

A PDF of NEXT Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NEXT Life Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NEXT Life Sciences

NEXT Life Sciences, Inc. has marked its entry as a revolutionary game-changer in the medical device industry. The company has introduced Plan A™, a non-hormonal, reversible procedure that aims to provide a groundbreaking male contraceptive solution. Next Life Sciences is determined to offer a non-hormonal, long-lasting, and reversible alternative, making it an innovative player in the Biotechnology and Life Sciences sectors. Founded in 2020, the company has successfully secured a seed round investment, with Seaside Ventures backing their vision. This strategic investment took place on 18 January 2024, showcasing investor confidence in NEXT Life Sciences' potential to disrupt the industry.

Business keywords: NEXT Life Sciences, medical device, male contraceptive solution, non-hormonal, reversible procedure, innovation, long lasting, scientific breakthrough

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Seaside Ventures
Seaside Ventures
18 Jan 2024
Seed Round $1.55M 1
Particular Ventures
Particular Ventures
02 Jun 2023
Venture Round Undisclosed 1
StartUp Health
StartUp Health
04 Aug 2022

NEXT Life Sciences Alternatives & Competitors

View All Alternatives
NEXT Life Sciences vs
Viltis
Viltis United States

Delivering expert consulting services to pharmaceutical, biotechnology, medical device, and diagnost...

6 employees
Biotechnology, Life Sciences
NEXT Life Sciences vs
Norgen Biotek
Norgen Biotek Canada

Facilitating Excellence in Research

84 employees
Biotechnology, Life Sciences
NEXT Life Sciences vs
hemotune AG
hemotune AG Switzerland

We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of...

Series B
25 employees
Biotechnology, Health Care
View all alternatives

FAQ About NEXT Life Sciences

NEXT Life Sciences Introduces Plan A™ A revolutionary, non-hormonal, reversible procedure that will bring the scientific
NEXT Life Sciences was founded in 2020.
NEXT Life Sciences operates in Biotechnology and Life Sciences. Its work centres on NEXT Life Sciences, medical device, male contraceptive solution and non-hormonal.
NEXT Life Sciences has approximately 12 employees.
NEXT Life Sciences has completed 3 funding rounds, raising a total of $1.55M. The latest funding stage is Seed.
Top alternatives and competitors to NEXT Life Sciences include Viltis, Norgen Biotek, hemotune AG, LAMPIRE Biological Laboratories, Inc., MediSpend. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NEXT Life Sciences and Viltis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NEXT Life Sciences, https://bouncewatch.com/company/next-life-sciences-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes